Appendix E
Biographies of Members of the Lucille P. Markey Charitable Trust Programs in Biomedical Sciences Committee
Enriqueta Bond, Ph.D., is President of the Burroughs-Wellcome Fund and will provide an important perspective on the committee as a leader in the philanthropic community. She is a former Executive Director of the Institute of Medicine of which she is also a member. Her research interests include genetics, molecular biology, and science policy. She has served on the IOM’s Board on Health Sciences Policy and on the Committee to Study Incentives for Resource Sharing in the Biomedical Sciences. She holds a Ph.D. in biology.
William T. Butler, M.D., is Chancellor of Baylor College of Medicine where he is also Professor of Internal Medicine and Professor of Microbiology and Immunology. He served as the College’s President and Chief Executive Officer from 1979 to 1996. Before joining the Baylor faculty in 1966, Dr. Butler served as the chief clinical associate in the Laboratory of Clinical Medicine at the National Institute of Allergy and Infectious Diseases at the NIH. He is on the boards of Browing-Ferris Industries, C. R. Bard, Inc., and Lyondell Petrochemical, where he is Chairman of the Board. Dr. Butler has done extensive research on the effects of corticosteroids and other drugs on the immune system and on the mechanism of rejection of organ transplants. He has authored numerous publications in the fields of immunology, infectious disease, and medical administration. Dr. Butler holds an M.D. (1958) from Western Reserve University and a B.A. (1954) from Oberlin College. Dr. Butler is a member of the Institute of Medicine.
Elaine K. Gallin, Ph.D., is the Program Director for Medical Research at The Doris Duke Charitable Foundation. Dr. Gallin’s research involves the characterization of ion transport mechanisms in macrophages, leukocyte-endothelial cell interactions, and the effects of ionizing radiation of leukocyte function and vascular integrity. She received her B.S. from Cornell University, her M.S. from Hunter College, and her Ph.D. from City University, New York. She has held positions at the Uniformed Services University and Georgetown University Medical School, was a Congressional Fellow on the Public Policy Committee, and is a member of the Physiology Study Section at NIH.
Georgine Pion, Ph.D., is Research Associate Professor of Psychology and Human Development and Senior Fellow with the Vanderbilt Institute for Public Policy Studies at Vanderbilt University. She received her Ph.D. in social-environmental psychology from Claremont Graduate School in 1980 and did postdoctoral research training in the Division of Methodology and Evaluation Research at Northwestern University. She has served on committees involved in the evaluation of research and health professional training programs and gender differences in the career development of scientists for the National Research Council, the National Science Foundation, and the National Institute of Mental Health. Currently, she is involved in directing an evaluation of the neuroscience peer review process at NIH, evaluating the outcomes of new instructional strategies in biomedical engineering education, and assessing the outcomes of postdoctoral research training programs sponsored by the Burroughs Wellcome Fund and other foundations. She is an Associate of the National Academy of Sciences
Mary-Lou Pardue, Ph.D., is the Boris Magasanik Professor of Biology at the Massachusetts Institute of Technology and a member of the National Academy of Sciences. As a geneticist and cell biologist, she has studied eukaryotic chromosomes with emphasis on sequences involved in the structure and function of chromosomes as organelles. She served as president of both the Genetics Society of America and the American Society for Cell Biology and was Chair of the Institute of Medicine Committee on Understanding the Biology of Sex and Gender Difference. She received a Ph.D. from Yale University in 1970.
Lloyd Hollingsworth Smith, M.D., is Professor Emeritus of Medicine and a former Associate Dean of the School of Medicine at the University of California, San Francisco. His areas of expertise include biochemistry, endocrinology and metabolism, internal medicine, and medical genetics. His interests and capabilities also include medical center administration,
medical education, training of investigators, and medical research policy. Dr. Smith holds an M.D. (1948) from Harvard Medical School and a B.A. (1944) from Washington & Lee University. Dr. Smith is a past member of the Board of Overseers of Harvard University. He is a member of the Institute of Medicine. He has previously served on the Committee to Study Strategies to Strengthen the Scientific Excellence of the NIH Intramural Research Program.
Lee Sechrest, Ph.D., is Professor of Psychology at the University of Arizona. His primary interest is in development and improvement of methods for research and data analysis, particularly for research in field settings. He is also involved in program evaluation. Substantive areas include health and mental health services, clinical psychology, and personality. Additional areas of expertise include research methodology, measurement, program evaluation, quality assurance in service delivery, and quality of scientific information. He is interested and involved in matters having to do with the development of psychology as a responsible, science-based profession. Before coming to Arizona, he held faculty positions in Pennsylvania State University, Northwestern University, Florida State University, and the University of Michigan. He received his Ph.D. from the Ohio State University. Dr. Sechrest has served on five NRC study committees, including the Panel to Study Gender Differences in the Career Outcomes of Science and Engineering Ph.D.s.
Virginia Weldon, M.D., is retired Senior Vice President for Public Policy with the Monsanto Company. In this position she identifies public policy issues affecting the company and plans for and orchestrates Monsanto’s approach to these issues. Prior to joining Monsanto in 1989, Dr. Weldon was Professor of Pediatrics and Associate Vice Chancellor for Medical Affairs at the Washington University School of Medicine. Dr. Weldon is on the Board of Directors of G.D. Searle & Company, The NutraSweet Company, and the Monsanto Fund. She holds an M.D. (1962) from the University of Buffalo and an A.B. (1957) from Smith College. She is a member of the Institute of Medicine and serves on the Report Review Committee of the National Research Council and Institute of Medicine.
James Wyngaarden, M.D., is Professor Emeritus at Duke University. At Duke, Dr. Wyngaarden served as Associate Vice Chancellor for Health Affairs, Chief of Staff and Physician-in-Chief at Duke University Hospital, and Frederic M. Hanes Professor and Chairman, Department of Medicine at the Duke University School of Medicine. From 1982 to 1989, Dr. Wyngaarden was Director, U.S. National Institutes of Health, and from 1989 to 1990 was Associate Director for Life Sciences, White House Office
